Qin D, Xi P, Huang K, Jiang L, Yao Z, Wei R
Front Med (Lausanne). 2024; 11:1486750.
PMID: 39712186
PMC: 11659012.
DOI: 10.3389/fmed.2024.1486750.
Ang A, Michaelides A, Chelala C, Ullah D, Kocher H
Ann Hepatobiliary Pancreat Surg. 2024; 28(2):248-261.
PMID: 38556877
PMC: 11128784.
DOI: 10.14701/ahbps.23-149.
Qin D, Wei R, Huang K, Wang R, Ding H, Yao Z
J Cancer Res Clin Oncol. 2023; 149(10):7805-7817.
PMID: 37032378
DOI: 10.1007/s00432-023-04703-4.
Minard L, Fisher J, Broadfield L, Walsh G, Sketris I
Front Pharmacol. 2022; 13:836864.
PMID: 35401210
PMC: 8987150.
DOI: 10.3389/fphar.2022.836864.
He C, Cai Z, Zhang Y, Lin X
J Oncol. 2021; 2021:3809095.
PMID: 34721578
PMC: 8553472.
DOI: 10.1155/2021/3809095.
Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data.
Jiang Y, Yuan H, Li Z, Ji X, Shen Q, Tuo J
Cancer Biol Med. 2021; .
PMID: 34486877
PMC: 8832952.
DOI: 10.20892/j.issn.2095-3941.2020.0634.
Multi-institutional development and external validation of machine learning-based models to predict relapse risk of pancreatic ductal adenocarcinoma after radical resection.
Li X, Yang L, Yuan Z, Lou J, Fan Y, Shi A
J Transl Med. 2021; 19(1):281.
PMID: 34193166
PMC: 8243478.
DOI: 10.1186/s12967-021-02955-7.
The Effect of CoQ Supplementation on Quality of Life in Women with Breast Cancer Undergoing Tamoxifen Therapy: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Hosseini S, Zahrooni N, Ahmadzadeh A, AhmadiAngali K, Assarehzadegan M
Psychol Res Behav Manag. 2020; 13:151-159.
PMID: 32110123
PMC: 7039424.
DOI: 10.2147/PRBM.S241431.
A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection.
He C, Huang X, Zhang Y, Cai Z, Lin X, Li S
Front Oncol. 2019; 9:1197.
PMID: 31781499
PMC: 6861378.
DOI: 10.3389/fonc.2019.01197.
Clinicopathological Features, Recurrence Patterns, and Prognosis of Pancreatic Adenocarcinoma with Normal Serum CA19-9. A Consecutive Series of 154 Cases from a Single Institute.
Zhao Y, Wang C
J Gastrointest Surg. 2019; 24(4):855-865.
PMID: 30945087
DOI: 10.1007/s11605-019-04209-w.
Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data.
Ye X, Mahmud S, Skrabek P, Lix L, Johnston J
BMJ Open. 2017; 7(7):e015106.
PMID: 28716788
PMC: 5734550.
DOI: 10.1136/bmjopen-2016-015106.
A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival.
Graham C, Orr C, Bricks C, Hopman W, Hammad N, Ramjeesingh R
Curr Oncol. 2017; 23(6):e583-e588.
PMID: 28050148
PMC: 5176385.
DOI: 10.3747/co.23.3204.
Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall Survival.
Shahinian J, Fuellgraf H, Tholen S, Mastroianni J, Knopf J, Kuehs M
J Cancer. 2016; 7(14):2018-2027.
PMID: 27877217
PMC: 5118665.
DOI: 10.7150/jca.15864.
ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma.
Lin C, Wu W, Zhao G, Wang D, Lou W, Jin D
Medicine (Baltimore). 2016; 95(31):e4527.
PMID: 27495108
PMC: 4979862.
DOI: 10.1097/MD.0000000000004527.
Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinoma.
Ji F, Fu S, Guo Z, Pang H, Ju W, Wang D
Medicine (Baltimore). 2016; 95(27):e4065.
PMID: 27399091
PMC: 5058820.
DOI: 10.1097/MD.0000000000004065.
Characteristics affecting survival after locally advanced colorectal cancer in Quebec.
Perron L, Daigle J, Vandal N, Guertin M, Brisson J
Curr Oncol. 2015; 22(6):e485-92.
PMID: 26715887
PMC: 4687675.
DOI: 10.3747/co.22.2692.
A population-based study of the epidemiology of pancreatic cancer: a brief report.
Raju R, Coburn N, Liu N, Porter J, Seung S, Cheung M
Curr Oncol. 2015; 22(6):e478-84.
PMID: 26715886
PMC: 4687674.
DOI: 10.3747/co.22.2653.
Breast and cervical cancer screening behaviours among colorectal cancer survivors in Nova Scotia.
Corkum M, Urquhart R, Kephart G, Hayden J, Porter G
Curr Oncol. 2014; 21(5):e670-7.
PMID: 25302037
PMC: 4189571.
DOI: 10.3747/co.21.2090.
Relative survival analysis using the Centers for Disease Control and Prevention's National Program of Cancer Registries Surveillance System Data, 2000-2007.
Wilson R, Ryerson A, Zhang K, Dong X
J Registry Manag. 2014; 41(2):72-6.
PMID: 25153012
PMC: 4361070.
Stage, treatment and outcomes for patients with breast cancer in British Columbia in 2002: a population-based cohort study.
Davidson A, Chia S, Olson R, Nichol A, Speers C, Coldman A
CMAJ Open. 2014; 1(4):E134-41.
PMID: 25077115
PMC: 3985980.
DOI: 10.9778/cmajo.20130017.